AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2004
May 20, 2004
29875_dirs_2004-05-19_dae1228d-8c63-408c-b43e-19d3784e9feb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CORP (CVS)
CIK: 0000064803
Period of Report: 2004-05-18
Reporting Person: RYAN THOMAS M (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-05-18 | Common Stock | M | 2900 | $16.7223 | Acquired | 65027 | Direct |
| 2004-05-18 | Common Stock | M | 123230 | $16.1811 | Acquired | 188257 | Direct |
| 2004-05-18 | Common Stock | S | 28030 | $40.25 | Disposed | 160227 | Direct |
| 2004-05-18 | Common Stock | S | 25200 | $40.2 | Disposed | 135027 | Direct |
| 2004-05-18 | Common Stock | S | 72900 | $40.1 | Disposed | 62127 | Direct |
| 2004-05-19 | Common Stock | M | 197100 | $16.7223 | Acquired | 259227 | Direct |
| 2004-05-19 | Common Stock | S | 40400 | $40.15 | Disposed | 218827 | Direct |
| 2004-05-19 | Common Stock | S | 42800 | $40.16 | Disposed | 176027 | Direct |
| 2004-05-19 | Common Stock | S | 52600 | $40.17 | Disposed | 123427 | Direct |
| 2004-05-19 | Common Stock | S | 25700 | $40.18 | Disposed | 97727 | Direct |
| 2004-05-19 | Common Stock | S | 5700 | $40.19 | Disposed | 92027 | Direct |
| 2004-05-19 | Common Stock | S | 4600 | $40.2 | Disposed | 87427 | Direct |
| 2004-05-19 | Common Stock | S | 500 | $40.21 | Disposed | 86927 | Direct |
| 2004-05-19 | Common Stock | S | 5800 | $40.22 | Disposed | 81127 | Direct |
| 2004-05-19 | Common Stock | S | 6600 | $40.23 | Disposed | 74527 | Direct |
| 2004-05-19 | Common Stock | S | 4600 | $40.24 | Disposed | 69927 | Direct |
| 2004-05-19 | Common Stock | S | 7800 | $40.25 | Disposed | 62127 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-05-18 | Stock Option | $16.1811 | M | 123230 | Disposed | 2005-04-11 | Common Stock (123230) | Direct |
| 2004-05-18 | Stock Option | $16.7223 | M | 2900 | Disposed | 2006-04-14 | Common Stock (2900) | Direct |
| 2004-05-19 | Stock Option | $16.7223 | M | 197100 | Disposed | 2006-04-14 | Common Stock (197100) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 482809 | Indirect |
| ESOP Preference Stock | 1408 | Indirect |
| Common Stock (Restricted) | 171711 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $23 | 2007-02-17 | Common Stock (391320) | 391320 | Direct |
| Stock Option | $25.125 | 2013-01-09 | Common Stock (450000) | 450000 | Direct |
| Stock Option | $29.925 | 2012-01-02 | Common Stock (506062) | 506062 | Direct |
| Stock Option | $35.335 | 2011-01-08 | Common Stock (200000) | 200000 | Direct |
| Stock Option | $36.6953 | 2008-02-27 | Common Stock (195660) | 195660 | Direct |
| Stock Option | $37.3125 | 2008-03-12 | Common Stock (600000) | 600000 | Direct |
| Stock Option | $38.5625 | 2010-01-03 | Common Stock (200000) | 200000 | Direct |
| Stock Option | $50 | 2009-03-10 | Common Stock (150000) | 150000 | Direct |
| Stock Option | $60.525 | 2011-03-07 | Common Stock (250000) | 250000 | Direct |
| Phantom Stock Credits | $1 | Common Stock (614) | 614 | Direct |
Footnotes
F1: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan.
F2: Includes dividend reinvestment shares acquired during the course of the year.
F3: Reflects stock beneficially owned pursuant to issuer's ESOP Plan.
F4: Reflects 2002 and 2003 year end company match share credits of 33 and 581, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3